Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Neutral

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Senti Biosciences, Inc. Common Stock (SNTI)

Biological Products, (no Disgnostic Substances)

https://www.sentibio.com

Senti Biosciences Inc is a preclinical biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. Its lead product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated OR+NOT off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma. It also develops SENTI-401, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate colorectal cancer/CRC cells.

2 CORPORATE DRIVE, FIRST FLOOR
SOUTH SAN FRANCISCO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/09/2022

Market Cap

10,806,393

Shares Outstanding

44,550,000

Weighted SO

44,545,186

Total Employees

N/A

Upcoming Earnings

N/A

Beta

2.7490

Last Div

0.0000

Range

1.52-8.48

Chg

0.0100

Avg Vol

766896

Mkt Cap

10806393

Exch

NASDAQ

Country

US

Phone

(650) 382-3281

DCF Diff

N/A

DCF

0.0000

Div Yield

0.0000

P/S

18.3782

EV Multiple

-0.7642

P/FV

0.2444

Div Yield %

0.0000

P/E

-0.1895

PEG

0.0098

Payout

0.0000

Current Ratio

4.8896

Quick Ratio

4.8896

Cash Ratio

1.7490

DSO

11585.0255

DIO

0.0000

Op Cycle

11585.0255

DPO

14.3244

CCC

11570.7011

Gross Margin

-50.1786

Op Margin

-156.3946

Pretax Margin

-133.7024

Net Margin

-96.8588

Eff Tax Rate

0.0299

ROA

-0.6553

ROE

-0.9109

ROCE

-1.1813

NI/EBT

0.7244

EBT/EBIT

0.8549

EBIT/Rev

-156.3946

Debt Ratio

0.4112

D/E

0.8096

LT Debt/Cap

0.4149

Total Debt/Cap

0.4474

Int Coverage

-82.6978

CF/Debt

-1.1875

Equity Multi

1.9687

Rec Turnover

0.0315

Pay Turnover

25.4809

Inv Turnover

0.0000

FA Turnover

0.0153

Asset Turnover

0.0068

OCF/Share

-9.2832

FCF/Share

-9.6938

Cash/Share

3.4689

OCF/Sales

-72.1820

FCF/OCF

1.0442

CF Coverage

-1.1875

ST Coverage

-9.5808

CapEx Coverage

-22.6121

Div&CapEx Cov

-22.6121

P/BV

0.2444

P/B

0.2444

P/S

18.3782

P/E

-0.1895

P/FCF

-0.2438

P/OCF

-0.2542

P/CF

-0.2542

PEG

0.0098

P/S

18.3782

EV Multiple

-0.7642

P/FV

0.2444

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation